Compare AAON & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAON | AXSM |
|---|---|---|
| Founded | 1988 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.0B |
| IPO Year | 1995 | 2015 |
| Metric | AAON | AXSM |
|---|---|---|
| Price | $103.32 | $240.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 17 |
| Target Price | $107.75 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 950.3K | 845.0K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $1,442,076,000.00 | N/A |
| Revenue This Year | $21.49 | $57.24 |
| Revenue Next Year | $13.70 | $55.88 |
| P/E Ratio | $224.33 | ★ N/A |
| Revenue Growth | ★ 20.11 | N/A |
| 52 Week Low | $62.00 | $96.09 |
| 52 Week High | $150.46 | $260.19 |
| Indicator | AAON | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | 51.12 |
| Support Level | $87.14 | $236.44 |
| Resistance Level | $108.50 | $256.40 |
| Average True Range (ATR) | 6.01 | 9.57 |
| MACD | -0.41 | -0.26 |
| Stochastic Oscillator | 11.85 | 56.90 |
AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.